• Celemics granted stock options covering 155,500 common shares to 40 employees, to be settled through newly issued shares.
• Exercise price set at KRW 11,320 per share.
• Options become exercisable from Oct. 6, 2028, with an expiry on Oct. 5, 2033.
• Board resolution dated Oct. 6, 2026; total options granted outstanding now stand at 155,500 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Celemics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000438), on October 06, 2026, and is solely responsible for the information contained therein.